“2018 is going to be the year of LDN” — LDN Radio Show
This month, I was interviewed on the LDN Radio Show alongside a good friend and colleague, Dr. Nicholas J. Palermo, to discuss a compounded pharmaceutical that’s proving to be one of the most promising treatments for inflammatory conditions ranging from Crohn’s to fatigue to chronic pain: Low Dose Naltrexone (LDN).
Among the first pharmacies to compound low-dose naltrexone (LDN), we’re also one of the top researchers on it and have worked with over 400 patients taking LDN with incredible results. I was honored to be invited onto the LDN Radio Show.
In the interview, we discuss:
- Why we first became interested in LDN
- Real patient results using LDN
- The benefits of LDN for particular health conditions
- How LDN fits into the broader functional medicine picture
Listen to the full LDN Radio Show interview:
LDN is an incredible tool, and what interests us most about it is that it’s not a band-aid approach. LDN actually addresses a foundational cause of inflammation and chronic health conditions, a process which we explain in our full blog post here.
I am actively lecturing on LDN at many schools and universities and welcome the opportunity to speak to your organization as well. Contact us here to find out more about my speaking engagements.